Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$1.04
-0.16-12.92%
Last update: Oct 6, 4:23 PM
$1.01
-0.19-15.83%
PDS Biotechnology Corp (PDSB) Stock Price, Quote, News & History
PDSBNASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer,...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of PDS Biotechnology (NASDAQ:PDSB) through any online brokerage.
Other companies in PDS Biotechnology’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
PDS Biotechnology has a consensus price target of $8.75.
The stock price for PDS Biotechnology (NASDAQ: PDSB) is $1.01 last updated October 6, 2026 at 4:23 PM EDT.
There are no upcoming dividends for PDS Biotechnology.
PDS Biotechnology does not have any upcoming earnings scheduled.
There is no upcoming split for PDS Biotechnology.
PDS Biotechnology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
